Provided by Tiger Fintech (Singapore) Pte. Ltd.

Brainsway Ltd.

8.95
-0.2600-2.82%
Post-market: 8.950.00000.00%18:47 EDT
Volume:33.72K
Turnover:305.00K
Market Cap:168.88M
PE:80.83
High:9.19
Open:8.96
Low:8.83
Close:9.21
Loading ...

Company Profile

Company Name:
Brainsway Ltd.
Exchange:
NASDAQ
Establishment Date:
2003
Employees:
120
Office Location:
16 Hartum St,Har Hotzvim,Jerusalem,Israel
Zip Code:
9777516
Fax:
- -
Introduction:
Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, the Asia Pacific, Europe, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

Directors

Name
Position
Avner Hagai
Vice Chairman of the Board
David Zacut
Chairman of the Board
Abraham Zangen
Director
Avner Lushi
Director
Eti Mitrany
Director
Gavriel Magen
Director
Karen Sarid
Director
Orly Uri
Director
Yossi Ben Shalom
Director

Shareholders

Name
Position
Christopher R. von Jako
President and Chief Executive Officer
Hadar Levy
Chief Financial Officer & Chief Operations Officer
Amit Ginou
Vice President Field and Clinical Operations
Moria Ankri
Vice President Research and Development
Yiftach Roth
Chief Scientist